Mon.Jan 13, 2025

article thumbnail

DNA nanorobots can alter artificial cells

Science Daily: Pharmacology News

Scientists have succeeded in controlling the structure and function of biological membranes with the help of 'DNA origami'. The system they developed may facilitate the transportation of large therapeutic loads into cells. This opens up a new way for the targeted administration of medication and other therapeutic interventions. Thus, a very valuable instrument can be added to the toolbox of synthetic biology.

DNA 322
article thumbnail

Evaluating GenMol as a Generalist Foundation Model for Molecular Generation

Nvidia Developer: Drug Discovery

Traditional computational drug discovery relies almost exclusively on highly task-specific computational models for hit identification and lead optimization. Traditional computational drug discovery relies almost exclusively on highly task-specific computational models for hit identification and lead optimization. Adapting these specialized models to new tasks requires substantial time, computational power, and expertisechallenges that grow when researchers simultaneously work across multiple ta

Drugs 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Engineering quantum entanglement at the nanoscale

Science Daily: Pharmacology News

Researchers have developed a drastically smaller and more energy efficient method of creating coveted photon pairs that influence each other from any distance. The technology could transform computing, telecommunications, and sensing.

article thumbnail

Moderna shares tumble on slashed sales guidance

BioPharma Drive: Drug Pricing

The company lost more than $3 billion in market value after cutting its forecast for 2025 revenue from its COVID-19 and RSV vaccines.

Vaccine 300
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

United States dementia cases estimated to double by 2060

Science Daily: Pharmacology News

A new study shows that the risk of developing dementia anytime after age 55 among Americans is 42%, more than double the risk reported by older studies.

325
325

More Trending

article thumbnail

Chornobyl dogs' genetic differences not due to mutation

Science Daily: Pharmacology News

Radiation-induced mutation is unlikely to have induced genetic differences between dog populations in Chornobyl City and the nearby Chornobyl Nuclear Power Plant.

309
309
article thumbnail

Fecal Transplants May Help People Who Have Diabetes, Gut Issues, Study Says

Drugs.com

Monday, Jan. 13, 2025 -- A fecal transplant could help people whose type 1 diabetes has fouled up their digestive system.Swallowing a handful of capsules filled with donor feces helped ease gut pain, nausea, bloating and diarrhea stemming from.

264
264
article thumbnail

NASA's Hubble tracks down a 'blue lurker' among stars

Science Daily: Pharmacology News

The name 'blue lurker' might sound like a villainous character from a superhero movie. But it is a rare class of star that NASA's Hubble Space Telescope explored by looking deeply into the open star cluster M67, roughly 2,800 light-years away.

297
297
article thumbnail

Multiple Violations Found At McDonald's Onion Supplier After Deadly E.Coli Outbreak

Drugs.com

MONDAY, Jan. 13, 2025 -- U.S. Food and Drug Administration (FDA) officials have uncovered dozens of violations at a McDonald's supplier tied to last year's deadly E.coli outbreak, which sickened over 100 people and led to a massive recall of onions.

FDA 246
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New study unveils breakthrough in understanding cosmic particle accelerators

Science Daily: Pharmacology News

Scientists have come a step closer to understanding how collisionless shock waves -- found throughout the universe -- are able to accelerate particles to extreme speeds.

288
288
article thumbnail

Link Between Gum Disease, Brain Function Exists, Small Study Says

Drugs.com

MONDAY, Jan. 13, 2025 -- Gum disease appears to disrupt brain activity, potentially increasing a persons risk of cognitive decline.People with gum disease experienced altered connections between different brain regions, compared to folks with good.

Disease 246
article thumbnail

World's oldest 3D map discovered

Science Daily: Pharmacology News

Researchers have discovered what may be the world's oldest three-dimensional map, located within a quartzitic sandstone megaclast in the Paris Basin.

Research 288
article thumbnail

Neglect Can Be as Damaging to Child Development as Abuse, in Some Ways

Drugs.com

MONDAY, Jan. 13, 2025 -- Simple neglect can be as damaging to a childs social development as physical, sexual or emotional abuse.Children whose basic needs arent met can have lifelong damage done to their ability to form friendships and romantic r.

246
246
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

X-ray flashes from a nearby supermassive black hole accelerate mysteriously

Science Daily: Pharmacology News

Astronomers observed flashes of X-rays coming from a supermassive black hole at a steadily increasing clip. The source could be the core of a dead star that's teetering at the black hole's edge.

279
279
article thumbnail

J&J to buy psychiatric drug developer Intra-Cellular for $14.6B

BioPharma Drive: Drug Pricing

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar depression.

article thumbnail

Tragic Pet Cat Deaths Linked to Bird Flu in Raw Milk

Drugs.com

MONDAY, Jan. 13, 2025 -- A California man's tragic story highlights the growing risks associated with bird flu infections in domestic animals.Joseph Journell of San Bernadino lost two of his beloved cats, a 14-year-old tabby, Alexander, and Tuxsie.

244
244
article thumbnail

Lilly pads cancer drug pipeline with Scorpion deal

BioPharma Drive: Drug Pricing

The pharma will spend up to $2.5 billion to acquire an experimental PI3K inhibitor from Scorpion, which will spin out a new company holding its employees and other assets.

Drugs 171
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Will We Have Fewer Doctors of Color?

Drugs.com

MONDAY, Jan. 13, 2025 -- Medical schools have experienced a steep decline in enrollment among Black and Hispanic students since the Supreme Court banned the consideration of race in admissions.The number of Black medical students fell by nearly 12%.

Doctors 130
article thumbnail

JPM25: Deals, Summit’s bravado and gene therapy headwinds

BioPharma Drive: Drug Pricing

Security was tight for the first day of the J.P. Morgan Healthcare Conference, which featured two deals involving privately held biotechs.

Therapies 164
article thumbnail

How To Handle Travel Stress

Drugs.com

MONDAY, Jan. 13, 2025 -- Traffic, delays, disruptions due to storms or wildfires, and other surprises may be part of your next business or pleasure trip. In short: Travel is more stressful (and more expensive) than ever.But you don't have to.

130
130
article thumbnail

Biogen’s ‘cold and calculated’ offer to buy Sage receives a mixed reaction on Wall Street

BioPharma Drive: Drug Pricing

Analysts say the deal, which would give Biogen full control over the drug Zurzuvae, could be a smart financial move. Yet it's also unlikely to appease broader investor concerns.

Drugs 156
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

First-Time Moms In This State May Be Using Welfare for Paid Family Leave

Drugs.com

MONDAY, Jan. 13, 2025 (HealthDay news) -- Low-income single mothers appear to be using welfare as a form of paid family leave following childbirth.Most women who enter the Temporary Assistance for Needy Families (TANF) program after childbirth are.

130
130
article thumbnail

Lack of regulatory harmonization and other challenges facing clinical services organizations in the APAC market

BioPharma Drive: Drug Pricing

How clinical services organizations are overcoming challenges in the APAC market.

Marketing 130
article thumbnail

Applying Technology Advancements to Overcome Challenges in Clinical Trials

Fierce BioTech

Applying Technology Advancements to Overcome Challenges in Clinical Trials pesurya Mon, 01/13/2025 - 13:14 Tue, 03/11/2025 - 11:00 Resource Type Webinar Marc Lisi Priyanka Sharma Duration 60 Minutes As technology evolves at a rapid pace, it promises solutions to myriad problems, from streamlining workflows to advancing life-saving therapies. In the world of clinical trials, where precision and compliance are critical, the role of technology is even more significant.

article thumbnail

Atop the Oregon Cascades, team finds a huge buried aquifer

Science Daily: Pharmacology News

Scientists have mapped the amount of water stored beneath volcanic rocks at the crest of the central Oregon Cascades and found an aquifer many times larger than previously estimated -- at least 81 cubic kilometers. The finding has implications for the way scientists and policymakers think about water in the region -- an increasingly urgent issue across the Western United States as climate change reduces snowpack, intensifies drought and strains limited resources.

294
294
article thumbnail

Covalent Plant Natural Product that Potentiates Antitumor Immunity

Covalent Modifiers

Misao Takemoto, Sara Delghandi, Masahiro Abo, Keiko Yurimoto, Minami Odagi, Vaibhav Pal Singh, Jun Wang, Reiko Nakagawa, Shin-ichi Sato, Yasushi Takemoto, Asmaa M. A. S. Farrag, Yoshimasa Kawaguchi, Kazuo Nagasawa, Tasuku Honjo, Kenji Chamoto, and Motonari Uesugi Journal of the American Chemical Society 2025 DOI: 10.1021/jacs.4c17837 Despite the unprecedented therapeutic potential of immune checkpoint antibody therapies, their efficacy is limited partly by the dysfunction of T cells within the c